share_log

Biotricity Analyst Ratings

Biotricity Analyst Ratings

生物分析師評級
Benzinga Analyst Ratings ·  2023/02/15 06:09
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
02/15/2023 184.33% HC Wainwright & Co. → $2 Reiterates → Buy
07/15/2022 Maxim Group Downgrades Buy → Hold
07/15/2022 184.33% HC Wainwright & Co. $6 → $2 Maintains Buy
03/07/2022 610.83% Lake Street → $5 Initiates Coverage On → Buy
11/23/2021 753% HC Wainwright & Co. → $6 Initiates Coverage On → Buy
07/01/2021 895.17% Northland Capital Markets → $7 Initiates Coverage On → Outperform
日期 上行/下行 分析公司 目標價格變化 評級變化 上一次/當前評級
02/15/2023 184.33% HC Wainwright公司 →$2 重申 →購買
07/15/2022 - Maxim集團 評級下調 購買→Hold
07/15/2022 184.33% HC Wainwright公司 $6→$2 維護
03/07/2022 610.83% 萊克街 →$5 開始承保 →購買
2021年11月23日 753% HC Wainwright公司 →$6 開始承保 →購買
07/01/2021 895.17% 北國資本市場 →$7 開始承保 →跑贏大盤

What is the target price for Biotricity (BTCY)?

Biotricity(BTCY)的目標價格是多少?

The latest price target for Biotricity (NASDAQ: BTCY) was reported by HC Wainwright & Co. on February 15, 2023. The analyst firm set a price target for $2.00 expecting BTCY to rise to within 12 months (a possible 184.33% upside). 4 analyst firms have reported ratings in the last year.

HC Wainwright&Co.於2023年2月15日報道了Biotricity(納斯達克代碼:BTCY)的最新目標價。這家分析公司將目標價定為2美元,預計BTCY將在12個月內上漲至(可能上漲184.33%)。去年有4家分析公司公佈了評級。

What is the most recent analyst rating for Biotricity (BTCY)?

Biotricity(BTCY)的最新分析師評級是什麼?

The latest analyst rating for Biotricity (NASDAQ: BTCY) was provided by HC Wainwright & Co., and Biotricity reiterated their buy rating.

納斯達克(Sequoia Capital:BTCY)的最新分析師評級由HC Wainwright&Co.提供,Biotricity重申其買入評級。

When is the next analyst rating going to be posted or updated for Biotricity (BTCY)?

Biotricity(BTCY)的下一次分析師評級將於何時發佈或更新?

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Biotricity, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Biotricity was filed on February 15, 2023 so you should expect the next rating to be made available sometime around February 15, 2024.

分析師在進行了廣泛的研究後得出了股票評級,其中包括查閱公共財務報表,與Biotricity的高管和客戶交談,以及聽取收益電話會議。大多數分析師每三個月就會這樣做一次,所以你每年應該會得到每家公司每家公司的4個評級。Biotricity的上一次評級是在2023年2月15日提交的,所以你應該預計下一次評級將在2024年2月15日左右提供。

Is the Analyst Rating Biotricity (BTCY) correct?

分析師對Biotricity(BTCY)的評級正確嗎?

While ratings are subjective and will change, the latest Biotricity (BTCY) rating was a reiterated with a price target of $0.00 to $2.00. The current price Biotricity (BTCY) is trading at is $0.70, which is within the analyst's predicted range.

雖然評級是主觀的,並將發生變化,但最新的Biotricity(BTCY)評級被重申,目標價在0.00美元至2.00美元之間。Biotricity(BTCY)目前的交易價格為0.70美元,在分析師的預測範圍內。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論